secwatch / observer
8-K filed January 5, 2024, 6:59 PM ET ticker TENX CIK 0000034956
other confidence high sentiment neutral materiality 0.50

Tenax Therapeutics announces 1-for-80 reverse stock split effective Jan 2, 2024

TENAX THERAPEUTICS, INC.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

TENAX THERAPEUTICS, INC.: Effected a 1-for-80 reverse stock split of common stock via Certificate of Amendment to Certificate of Incorporation (effective 2024-01-02).

Change
charter amendment
Effective
2024-01-02
Exact text from the filing
Tenax Therapeutics, Inc. (the "Company") filed a Certificate of Amendment to the Company’s Certificate of Incorporation, as amended (the “Certificate of Amendment”) with the Secretary of State of Delaware for the purpose of effecting a reverse stock split of the outstanding shares of the Company’s common stock at a ratio of one share for every 80 shares outstanding (the “Reverse Stock Split”), so that every 80 outstanding shares of common stock before the Reverse Stock Split represents one share of common stock after the Reverse Stock Split.
View on SEC.gov

51 governance changes filed in the last 30 days. Browse all governance changes →

TENAX THERAPEUTICS, INC. filing history →

Source: SEC EDGAR
accession 0001654954-24-000269
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.